NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) — Citeline, a Norstella company providing robust data and expert business intelligence to the pharmaceutical industry, will offer exclusive access to insights from the 42nd Annual J.P. Morgan Healthcare Conference (JPM) Jan. 8–11, 2024 in San Francisco. JPM, the industry’s largest healthcare investment

Fiammetta Rocco, Dr. Rafal Niemojewski, Maya Allison, Sultan Sooud Al Qassemi, Manal Ataya. Culture Summit 2022. Courtesy DCT Abu Dhabi The Summit will bring together leaders from fields of art, heritage, media, museums, music, public policy and technology from over 90 countries to explore our changing relation to time Organised

Single SoC Supports One to 34 Billion-Parameter, Multi-Modal LLMs With Low Power Consumption, Enabling Generative AI for Edge Endpoint Devices Ambarella’s New N1 SoC Supports Up to 34 Billion-Parameter, Multi-Modal Large Language Models With Low Power Consumption, Enabling Generative AI for Edge Endpoint Devices Ambarella is demonstrating multi-modal LLMs running

Nasdaq European Markets welcomed 33 listings, including 7 initial public offerings (IPOs), raising a total of EUR 431 million risk capital and EUR 11.6 bn in secondary offerings Nasdaq celebrated its 130th company to transfer from Nasdaq First North Growth Market to Main Market STOCKHOLM, Sweden, Jan. 08, 2024 (GLOBE

Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva Colobreathe® is an inhaled antibiotic for the management of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients The acquisition will help ensure continued access to an important medicine for this vulnerable patient population First rare disease medicine to be added